IPOX Schuster IPOX Schuster

The IPOX® Update 7/31/2026

Global IPO activity spans major U.S., European and Asia-Pacific deals, led by potential multibillion-dollar listings from CyrusOne, Westinghouse and Nscale. Recent U.S. debuts from Jersey Mike’s and Reformation showed cautious investor sentiment, increasing pressure on pricing and fundraising expectations. Smaller transactions include Braveheart Bio, Space-Eyes, Karman Line, Vogenx and NASN Intelligent Tech. Across sectors, investors remain interested in established brands, nuclear energy, data centers, biotechnology, defense technology and artificial-intelligence infrastructure, despite heightened volatility and greater scrutiny of financial performance metrics.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on Westinghouse’s U.S. IPO Filing

IPOX® Associate Lukas Muehlbauer was quoted by Reuters on Westinghouse Electric’s confidential U.S. IPO filing. He said the company’s investor appeal comes from offering exposure to nuclear growth through an established operating business and a well-known American industrial name. Muehlbauer added that energy-security concerns and rising electricity demand from data centers have improved market sentiment toward nuclear power.

Read More
IPOX Schuster IPOX Schuster

Bloomberg: IPOX® Founder Josef Schuster Comments on Weak U.S. IPO Debuts and Rising Equity Risk

IPOX® CEO Josef Schuster was featured in Bloomberg's ECM Watch, discussing muted U.S. IPO debuts and rising equity risk. Following mixed first-day performances from Jersey Mike’s and Reformation, Schuster said elevated risk is pressuring the IPO market and making investors more selective. He added that prospective issuers may need greater flexibility on pricing expectations and fundraising targets. Bloomberg also cited the IPOX® 100 U.S. as a benchmark for recent large U.S. IPOs and spinoffs amid volatile market conditions.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® Associate Lukas Muehlbauer Comments on Jersey Mike’s NYSE Debut

IPOX® Associate Lukas Muehlbauer was quoted by Reuters on Jersey Mike’s NYSE debut, noting that raising roughly $1 billion showed investors remain willing to back large, established consumer brands. The sandwich chain’s shares opened 8.7% below their $23 IPO price, valuing the company at about $6.7 billion. Muehlbauer also cautioned against overinterpreting the first-day decline, citing broader market volatility as U.S. IPO activity continues to recover across technology, defense, industrial, consumer, and retail sectors this year after a prolonged slowdown.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® VP Kat Liu Comments on Reformation’s NYSE Debut and Investor Priorities

Reuters reported that Permira-backed womenswear retailer Reformation was valued at $886.1 million in its NYSE debut after shares opened at the $15 IPO price. IPOX® Vice President Kat Liu said investors now prioritize financial performance over sustainability narratives, though sustainability can still strengthen brands and customer loyalty. Liu also noted that Reformation’s high share of returning customers signals genuine loyalty, lower retention costs, stronger lifetime spending, and more predictable revenue as the company pursues store expansion and product diversification plans.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 7/24/2026

Jersey Mike’s leads the pipeline with a potential $1.09 billion NYSE offering, followed by Reformation, Amapá Minerals and Saudi lubricant producer Petrolube. Other notable candidates include Lyntris, AlphaSense, Moonshot AI, AgiBot, TAWAL and Pepkor’s planned fintech spin-off. Together, the transactions span North America, Asia-Pacific, MENA and Africa, reflecting continued demand for sizable public-market opportunities across diverse industries and global markets.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® VP Kat Liu Comments on Reformation’s $1 Billion IPO Target

Reuters reports that Permira-backed womenswear retailer Reformation is targeting a valuation of up to $1 billion in its U.S. IPO. IPOX® Vice President Kat Liu said consumer companies can still attract investors, but few retail brands offer enough recognition and differentiation. She noted Reformation’s sustainability positioning must compete with price, fashion trends and convenience. Liu added that its direct-to-consumer model improves control over pricing, merchandising, customer relationships and inventory, but is not a unique competitive advantage in today’s apparel market landscape.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 7/18/2026

Global IPO activity is accelerating, led by large technology and infrastructure deals. In the U.S., Switch, Anthropic, Holtec, JERA and YPF Electric Energy are pursuing or considering listings. Europe remains mixed, with Utmost and Howden advancing plans while AS Watson may delay. Asia-Pacific is especially active: CXMT has raised $8.6 billion, while Zhongji Innolight, Eoptolink, Shein, AirTrunk, DeepSeek and Kopi Kenangan prepare offerings, though Syngenta’s Hong Kong IPO could slip to 2027. Market conditions and regulatory approvals remain key uncertainties.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® CEO Josef Schuster Comments on YPF Electric Energy’s U.S. IPO Filing

IPOX® CEO Josef Schuster commented on YPF Electric Energy’s U.S. IPO filing, highlighting the company’s significant scale and position among Argentina’s leading utilities. He said the strong debut of Korea’s SK Hynix demonstrated that U.S. markets remain receptive to large foreign listings, helping motivate YPF Electric Energy to pursue a NYSE debut. The company reported a 45.8% increase in quarterly revenue and plans to trade under the ticker “YLUZ,” with investor interest supported by improving sentiment toward Argentina’s energy sector.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® Associate Lukas Muehlbauer Comments on Csquare’s NYSE Debut and Selective IPO Market

Reuters reported that Brookfield-backed data center provider Csquare was valued at $3.2 billion after a subdued NYSE debut, with shares closing below the $21 IPO price. IPOX® Research Associate Lukas Muehlbauer said investors viewed the company’s AI infrastructure exposure alongside substantial leverage and continued losses, prompting disciplined pricing. He added that the successful deal still showed the IPO market remains open to AI infrastructure companies, although investor demand appears selective rather than overheated in the current, cautious new-issue market environment.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® CEO Josef Schuster Comments on Standard Nuclear’s Reduced IPO and Valuation Pressures

IPOX® CEO Josef Schuster commented on Standard Nuclear’s decision to cut its proposed U.S. IPO by more than half, lowering its targeted valuation to $2.4 billion amid cautious investor sentiment. He said weak performance among recent IPOs, including SpaceX, is weighing on demand for high-risk, loss-making offerings. Schuster also noted that sector-specific weakness, reflected in declines for NuScale Power and Oklo, is creating a more challenging pricing environment ahead of Standard Nuclear’s planned NYSE debut during its New York launch.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 7/11/2026

Global IPO activity is gaining momentum across the United States, Europe and Asia-Pacific. DuPont Registry, Ennismore, Syntiant and Scribe Therapeutics are advancing U.S. listings, while Digi Spain has priced a €330 million offering at €5.60 per share. In Asia, AI chipmaker Rebellions is targeting a South Korean IPO in 2027, with a possible U.S. ADR to follow. The deals highlight renewed investor appetite across luxury, hospitality, telecom, biotechnology and artificial intelligence sectors amid improving market conditions and stronger global sentiment.

Read More
IPOX Schuster IPOX Schuster

Seeking Alpha: FPX ETF Tracking the IPOX® 100 U.S. Index Featured in Analysis of IPO Market Exposure

Seeking Alpha featured an analysis of the First Trust US Equity Opportunities ETF (FPX), highlighting the fund’s tracking of the IPOX® 100 U.S. Index. The article discusses FPX as a diversified ETF for exposure to U.S. companies that have recently gone public, with a focus on index methodology, sector positioning, recent performance, and risk profile. It also examines how IPO market trends, AI enthusiasm, and corporate spinoffs may shape the fund’s opportunity set.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 7/4/2026

Recent IPO activity shows renewed breadth across U.S. and European markets, with large listings and filings spanning restaurants, consumer retail, fintech, digital infrastructure, defence, telecom and healthcare real estate. In the U.S., Jersey Mike’s, Nutrabolt, iHerb and several Nasdaq debutants highlight stronger investor appetite, while Europe’s pipeline includes KNDS, Dusk, Infracore, Digi Spain and Smag. Although market volatility remains a constraint, IPO momentum appears to be broadening beyond AI-led growth stories and defensive consumer names across public equity markets today.

Read More